Veru Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for cardiometabolic and inflammatory diseases. Its pipeline includes enobosarm, an oral selective androgen receptor modulator (SARM) being developed to enhance GLP-1 RA weight loss by preserving lean mass and reducing fat, and sabizabulin, a microtubule disruptor for atherosclerotic cardiovascular disease inflammation. On December 30, 2024, Veru sold its FDA-approved FC2 Female Condom commercial product.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-17 | 2025-09-30 | 0001437749-25-038089 | EDGAR | 73K words |
| 2024-12-16 | 2024-09-30 | 0001437749-24-037576 | EDGAR | 82K words |
| 2023-12-08 | 2023-09-30 | 0000863894-23-000017 | EDGAR | 76K words |
| 2022-12-05 | 2022-09-30 | 0000863894-22-000017 | EDGAR | — |
| 2021-12-02 | 2021-09-30 | 0000863894-21-000013 | EDGAR | — |
| 2020-12-10 | 2020-09-30 | 0000863894-20-000021 | EDGAR | — |
| 2019-12-12 | 2019-09-30 | 0000863894-19-000014 | EDGAR | — |
| 2018-12-13 | 2018-09-30 | 0000863894-18-000011 | EDGAR | — |
| 2018-01-02 | 2017-09-30 | 0001562762-17-000231 | EDGAR | — |
| 2016-12-12 | 2016-09-30 | 0000863894-16-000032 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001437749-26-026664 | EDGAR | 31K words |
| 2026-02-11 | 2025-12-31 | 0001437749-26-003725 | EDGAR | 26K words |
| 2025-08-12 | 2025-06-30 | 0001437749-25-026072 | EDGAR | 53K words |
| 2025-05-08 | 2025-03-31 | 0001437749-25-015330 | EDGAR | 51K words |
| 2025-02-13 | 2024-12-31 | 0001437749-25-003734 | EDGAR | 49K words |
| 2024-08-08 | 2024-06-30 | 0001437749-24-025338 | EDGAR | 34K words |
| 2024-05-08 | 2024-03-31 | 0000863894-24-000011 | EDGAR | 32K words |
| 2024-04-01 | 2023-12-31 | 0000863894-24-000008 | EDGAR | 28K words |
| 2023-08-10 | 2023-06-30 | 0000863894-23-000009 | EDGAR | 30K words |
| 2023-05-11 | 2023-03-31 | 0000863894-23-000006 | EDGAR | 28K words |
| 2023-02-09 | 2022-12-31 | 0000863894-23-000003 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000863894-22-000013 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-08 | 0001193125-26-384430 | EDGAR | 4K words |
| 2026-08-10 | 0001193125-26-341187 | EDGAR | 5K words |
| 2026-03-13 | 0001437749-26-008216 | EDGAR | 14K words |
| 2026-02-11 | 0001193125-26-045527 | EDGAR | 4K words |
| 2025-12-17 | 0001193125-25-321663 | EDGAR | 5K words |
| 2025-10-30 | 0001193125-25-258565 | EDGAR | 1K words |
| 2025-09-26 | 0001437749-25-029912 | EDGAR | 1K words |
| 2025-08-27 | 0001437749-25-027858 | EDGAR | 1K words |
| 2025-08-12 | 0001437749-25-026037 | EDGAR | 1K words |
| 2025-08-12 | 0001193125-25-178463 | EDGAR | 4K words |
319 total filings indexed. 287 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000863894 |
| Ticker | VERU |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | WI |
| Website | https://www.verupharma.com |
| Listed | 1990-06-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VERU (~200 tokens, structured JSON with cryptographic provenance)